118 related articles for article (PubMed ID: 38775535)
1. Are monocyte-to-HDL and C-reactive protein-to-albumin ratios useful for the diagnosis and follow-up of Takayasu arteritis?
Kılınç EA; Varkal G; Kırmızıer G; Türk İ; Özer HTE
Rev Assoc Med Bras (1992); 2024; 70(5):e20231683. PubMed ID: 38775535
[TBL] [Abstract][Full Text] [Related]
2. The C-Reactive Protein/Albumin Ratio and Complete Blood Count Parameters as Indicators of Disease Activity in Patients with Takayasu Arteritis.
Seringec Akkececi N; Yildirim Cetin G; Gogebakan H; Acipayam C
Med Sci Monit; 2019 Feb; 25():1401-1409. PubMed ID: 30792377
[TBL] [Abstract][Full Text] [Related]
3. The role of mean platelet volume in patients with Takayasu arteritis.
Peng YF; Guo J; Deng YB
Ann Clin Biochem; 2017 Mar; 54(2):273-278. PubMed ID: 27329216
[TBL] [Abstract][Full Text] [Related]
4. [Association between platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio with disease activity in Takayasu arteritis patients].
Li ZQ; Zheng ZH; Du WL; Pang LX; Li Y; Wu ZB; Zhu P
Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Sep; 46(9):713-718. PubMed ID: 30293378
[No Abstract] [Full Text] [Related]
5. Value of contrast-enhanced ultrasonography of the carotid artery for evaluating disease activity in Takayasu arteritis.
Ma LY; Li CL; Ma LL; Cui XM; Dai XM; Sun Y; Chen HY; Huang BJ; Jiang LD
Arthritis Res Ther; 2019 Jan; 21(1):24. PubMed ID: 30651132
[TBL] [Abstract][Full Text] [Related]
6. Platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio associated with disease activity in patients with Takayasu's arteritis: a case-control study.
Pan L; Du J; Li T; Liao H
BMJ Open; 2017 May; 7(4):e014451. PubMed ID: 28473512
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of monocyte to HDL cholesterol ratio and other inflammatory markers in patients with psoriasis.
Sirin MC; Korkmaz S; Erturan I; Filiz B; Aridogan BC; Cetin ES; Yildirim M
An Bras Dermatol; 2020; 95(5):575-582. PubMed ID: 32711928
[TBL] [Abstract][Full Text] [Related]
8. Pentraxin-3 as a marker of disease activity in Takayasu arteritis.
Dagna L; Salvo F; Tiraboschi M; Bozzolo EP; Franchini S; Doglioni C; Manfredi AA; Baldissera E; Sabbadini MG
Ann Intern Med; 2011 Oct; 155(7):425-33. PubMed ID: 21969341
[TBL] [Abstract][Full Text] [Related]
9. Elevated serum 25-hydroxyvitamin D: a potential indicator of remission in Takayasu arteritis patients with normal ESR and CRP levels.
Liao H; Du J; Li F; Yang S; Qi G; Pan L
Clin Rheumatol; 2024 Jun; 43(6):1979-1987. PubMed ID: 38598024
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic features, treatment, and outcomes of Takayasu arteritis in a US cohort of 126 patients.
Schmidt J; Kermani TA; Bacani AK; Crowson CS; Cooper LT; Matteson EL; Warrington KJ
Mayo Clin Proc; 2013 Aug; 88(8):822-30. PubMed ID: 23849994
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of monocyte to high-density lipoprotein ratio, lymphocytes, monocytes, and platelets in psoriasis.
Aktaş Karabay E; Demir D; Aksu Çerman A
An Bras Dermatol; 2020; 95(1):40-45. PubMed ID: 31889591
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of blood parameters for community-acquired pneumonia.
Huang Y; Liu A; Liang L; Jiang J; Luo H; Deng W; Lin G; Wu M; Li T; Jiang Y
Int Immunopharmacol; 2018 Nov; 64():10-15. PubMed ID: 30144639
[TBL] [Abstract][Full Text] [Related]
13. Role of FDG PET-CT in Takayasu arteritis: sensitive detection of recurrences.
Tezuka D; Haraguchi G; Ishihara T; Ohigashi H; Inagaki H; Suzuki J; Hirao K; Isobe M
JACC Cardiovasc Imaging; 2012 Apr; 5(4):422-9. PubMed ID: 22498333
[TBL] [Abstract][Full Text] [Related]
14. NMR-Based Serum Metabolomics of Patients with Takayasu Arteritis: Relationship with Disease Activity.
Jain A; Kumar D; Guleria A; Misra DP; Zanwar A; Chaurasia S; Kumar S; Kumar U; Mishra SK; Goel R; Danda D; Misra R
J Proteome Res; 2018 Sep; 17(9):3317-3324. PubMed ID: 30095916
[TBL] [Abstract][Full Text] [Related]
15. Elevated chemokines concentration is associated with disease activity in Takayasu arteritis.
Dong H; Zhang Y; Zou Y; Chen Y; Yue J; Liu H; Jiang X
Cytokine; 2021 Jul; 143():155515. PubMed ID: 33849766
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Biological-Targeted Treatments in Takayasu Arteritis: Multicenter, Retrospective Study of 49 Patients.
Mekinian A; Comarmond C; Resche-Rigon M; Mirault T; Kahn JE; Lambert M; Sibilia J; Néel A; Cohen P; Hie M; Berthier S; Marie I; Lavigne C; Anne Vandenhende M; Muller G; Amoura Z; Devilliers H; Abad S; Hamidou M; Guillevin L; Dhote R; Godeau B; Messas E; Cacoub P; Fain O; Saadoun D;
Circulation; 2015 Nov; 132(18):1693-700. PubMed ID: 26354797
[TBL] [Abstract][Full Text] [Related]
17. Infliximab biosimilar CT-P13 therapy in patients with Takayasu arteritis with low dose of glucocorticoids: a prospective single-arm study.
Park EH; Lee EY; Lee YJ; Ha YJ; Yoo WH; Choi BY; Paeng JC; Suh HY; Song YW
Rheumatol Int; 2018 Dec; 38(12):2233-2242. PubMed ID: 30229280
[TBL] [Abstract][Full Text] [Related]
18. The efficacy of mycophenolate mofetil in treating Takayasu arteritis: a systematic review and meta-analysis.
Dai D; Wang Y; Jin H; Mao Y; Sun H
Rheumatol Int; 2017 Jul; 37(7):1083-1088. PubMed ID: 28364217
[TBL] [Abstract][Full Text] [Related]
19. Potential Role of Macrophage Phenotypes and CCL2 in the Pathogenesis of Takayasu Arteritis.
Kong X; Xu M; Cui X; Ma L; Cheng H; Hou J; Sun X; Ma L; Jiang L
Front Immunol; 2021; 12():646516. PubMed ID: 34079541
[TBL] [Abstract][Full Text] [Related]
20. Retrospective analysis of surgery versus endovascular intervention in Takayasu arteritis: a multicenter experience.
Saadoun D; Lambert M; Mirault T; Resche-Rigon M; Koskas F; Cluzel P; Mignot C; Schoindre Y; Chiche L; Hatron PY; Emmerich J; Cacoub P
Circulation; 2012 Feb; 125(6):813-9. PubMed ID: 22230484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
